These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35212878)

  • 21. Use of Opioid Agonist Therapy for Medicare Patients in 2013.
    Lembke A; Chen JH
    JAMA Psychiatry; 2016 Sep; 73(9):990-2. PubMed ID: 27438334
    [No Abstract]   [Full Text] [Related]  

  • 22. Trends in Opioid Use and Prescribing in Medicare, 2006-2012.
    Axeen S
    Health Serv Res; 2018 Oct; 53(5):3309-3328. PubMed ID: 29532477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin.
    Hartung DM; Johnston K; Cohen DM; Nguyen T; Deodhar A; Bourdette DN
    JAMA Netw Open; 2018 Jun; 1(2):e180482. PubMed ID: 30646086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid Prescribing by Nurse Practitioners in Medicare Part D: Impact of State Scope of Practice Legislation.
    Ladd E; Sweeney CF; Guarino A; Hoyt A
    Med Care Res Rev; 2019 Jun; 76(3):337-353. PubMed ID: 29148351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries.
    Singh P; Forman H; Adamson AS; Mostaghimi A; Ogdie AR; Oganisian A; Barbieri JS
    J Gen Intern Med; 2019 Feb; 34(2):176-178. PubMed ID: 30324292
    [No Abstract]   [Full Text] [Related]  

  • 27. Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use.
    Barnett ML; Olenski AR; Jena AB
    N Engl J Med; 2017 Feb; 376(7):663-673. PubMed ID: 28199807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Association between Industry Payments and Brand-Name Prescriptions in Otolaryngologists.
    Morse E; Hanna J; Mehra S
    Otolaryngol Head Neck Surg; 2019 Oct; 161(4):605-612. PubMed ID: 31547772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Industry Payments to Physicians for Opioid Products, 2013-2015.
    Hadland SE; Krieger MS; Marshall BDL
    Am J Public Health; 2017 Sep; 107(9):1493-1495. PubMed ID: 28787210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in Opioid Prescriptions Among Part D Medicare Recipients From 2007 to 2012.
    Kuo YF; Raji MA; Chen NW; Hasan H; Goodwin JS
    Am J Med; 2016 Feb; 129(2):221.e21-30. PubMed ID: 26522794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid Prescribing to Medicare Part D Enrollees, 2013-2017: Shifting Responsibility to Pain Management Providers.
    Romman AN; Hsu CM; Chou LN; Kuo YF; Przkora R; Gupta RK; Lozada MJ
    Pain Med; 2020 Nov; 21(7):1400-1407. PubMed ID: 31904839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An examination of opioid prescription for Medicare Part D patients among family practice prescribers.
    Pan K; Blankley AI; Hughes PJ
    Fam Pract; 2019 Jul; 36(4):467-472. PubMed ID: 30239656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in Opioid Prescribing Patterns Among Generalists and Oncologists for Medicare Part D Beneficiaries From 2013 to 2017.
    Agarwal A; Roberts A; Dusetzina SB; Royce TJ
    JAMA Oncol; 2020 Aug; 6(8):1271-1274. PubMed ID: 32469405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population.
    Bradford AC; Bradford WD; Abraham A; Bagwell Adams G
    JAMA Intern Med; 2018 May; 178(5):667-672. PubMed ID: 29610897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentration of Opioid-Related Industry Payments in Opioid Crisis Areas.
    Lee AJ; Bandari J; Macleod LC; Davies BJ; Jacobs BL
    J Gen Intern Med; 2019 Feb; 34(2):187-189. PubMed ID: 30402818
    [No Abstract]   [Full Text] [Related]  

  • 36. Opioid use in older adults and Medicare Part D.
    Sabety AH; Sherry TB; Maestas N
    Health Serv Res; 2021 Apr; 56(2):289-298. PubMed ID: 33462819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid Prescribing Practices of Neurosurgeons: Analysis of Medicare Part D.
    Khalid SI; Adogwa O; Lilly DT; Desai SA; Vuong VD; Mehta AI; Cheng J
    World Neurosurg; 2018 Apr; 112():e31-e38. PubMed ID: 29253702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations Between Industry Payments to Physicians for Antiplatelet Drugs and Utilization of Cardiac Procedures and Stents.
    Yanagisawa M; Blumenthal DM; Kato H; Inoue K; Tsugawa Y
    J Gen Intern Med; 2022 May; 37(7):1626-1633. PubMed ID: 34378113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study.
    Fleischman W; Agrawal S; King M; Venkatesh AK; Krumholz HM; McKee D; Brown D; Ross JS
    BMJ; 2016 Aug; 354():i4189. PubMed ID: 27540015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription Drug Monitoring Programs Produce a Limited Impact on Painkiller Prescribing in Medicare Part D.
    Yarbrough CR
    Health Serv Res; 2018 Apr; 53(2):671-689. PubMed ID: 28101955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.